Noble gases and neuroprotection: summary of current evidence
Authors:
- 1 July 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 34 (5) , 603-606
Abstract
Purpose of review: To summarize the current data on neuroprotection derived by noble gas treatment focusing on xenon and argon. Recent findings: Both xenon and argon have demonstrated neuroprotective properties in an array of disease models. However, current data for argon after traumatic brain injury (TBI) is conflicting. Recent human data is only available for xenon showing some beneficial aspects (fewer adverse events) but no effect on outcomes, such as incidence of postoperative delirium. Summary: Promising results are available for neuroprotection derived by noble gas treatment. Results for xenon are more consistent than those for argon. The mechanism of action of xenon (noncompetitive NMDA-receptor inhibition) is also better understood compared with that of argon. The evidence for argon's neuroprotective actions (particularly after TBI) remains uncertain.Keywords
This publication has 32 references indexed in Scilit:
- Nausea and Vomiting following Balanced Xenon Anesthesia Compared to Sevoflurane: A Post-Hoc Explorative Analysis of a Randomized Controlled TrialPLOS ONE, 2016
- Neuroprotective and neurorestorative potential of xenonCell Death & Disease, 2016
- Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trialThe Lancet Neurology, 2016
- Argon: Systematic Review on Neuro- and Organoprotective Properties of an “Inert” GasInternational Journal of Molecular Sciences, 2014
- Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotectionCritical Care, 2010
- Mechanistic Insights into Xenon Inhibition of NMDA Receptors from MD SimulationsThe Journal of Physical Chemistry B, 2010
- Competitive Inhibition at the Glycine Site of the N -Methyl-d-Aspartate Receptor Mediates Xenon Neuroprotection against Hypoxia–IschemiaAnesthesiology, 2010
- Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injuryCritical Care, 2009
- Neuroprotective and neurotoxic properties of the 'inert' gas, xenonBritish Journal of Anaesthesia, 2002
- The Anesthetic Properties of Xenon in Animals and Human Beings, with Additional Observations on KryptonScience, 1951